Understanding Inherited Breast Cancer
Breast cancer is the most commonly diagnosed cancer in the United States. In 2018, 266,120 women and 2,550 men...
Breast cancer is the most commonly diagnosed cancer in the United States. In 2018, 266,120 women and 2,550 men...
In a study published in the AACR’s journal Clinical Cancer Research, a team of scientists from the University of...
On Friday, the U.S. Food and Drug Administration (FDA) approved the molecularly targeted therapeutic olaparib (Lynparza) for treating certain...
Kent Osborne, MD, a codirector of SABCS, wrote a guest post for Cancer Research Catalyst in 2015 that details...
Several clinical trials are underway in which PARP inhibitors are being tested in breast cancers, mostly triple-negative breast cancers,...
Last week, the U.S. Food and Drug Administration (FDA) provided some good news for the breast cancer community just...
Earlier this year, a study published in Cancer Discovery, a journal of the American Association for Cancer Research (AACR),...
Earlier this week, the U.S. Food and Drug Administration (FDA) approved a new molecularly targeted therapeutic called neratinib (Nerlynx)...
Earlier this week, the U.S. Food and Drug Administration approved the molecularly targeted therapeutic ribociclib (Kisqali) for use in...
The fact that there are differences in screening mammography recommendations highlights the need for additional research into the benefits...